Yahoo
NasdaqGS - Delayed Quote USD

Ascendis Pharma A/S (ASND)

270.56 -0.56 (-0.21%)
At close: September 4 at 4:00:00 PM EDT
271.00 +0.44 (+0.16%)
After hours: September 4 at 7:39:57 PM EDT
Trade ASND on Coinbase

Earnings Trends

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 246.6M
Earnings 629.34M
Profit Margin 255.21%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
200M
400M
600M
0.0%
100.0%
200.0%

Revenue Estimate

Currency in EUR
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2026)
Next Year (2027)
No. of Analysts
16 16 18 18
Avg. Estimate
364.33M 411.05M 1.36B 2B
Low Estimate
352.4M 387.5M 1.33B 1.81B
High Estimate
376M 450.3M 1.41B 2.3B
Year Ago Sales
213.63M 247.5M 720.13M 1.36B
Sales Growth (year/est)
70.54% 66.08% 88.73% 47.31%

Earnings Estimate

GAAP
Normalized
Currency in EUR
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2026)
Next Year (2027)
No. of Analysts
3 3 4 4
Avg. Estimate
0.95 1.18 11.29 8.05
Low Estimate
0.68 0.67 3.61 6.64
High Estimate
1.09 1.51 15.41 8.75
Year Ago EPS
-- -- -- 11.29

Earnings History

GAAP
Normalized
Currency in EUR
3/31/2026
6/30/2026
EPS Est.
-0.08 0.77
EPS Actual
0.27 0.9
Difference
0.35 0.13
Surprise %
429.27% 17.39%

EPS Trend

GAAP
Normalized
Currency in EUR
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2026)
Next Year (2027)
Current Estimate
0.95 1.18 11.29 8.05
7 Days Ago
1.32 1.59 11.34 8.16
30 Days Ago
1.25 1.8 11.73 9.29
60 Days Ago
1.2 1.75 12.04 9.19
90 Days Ago
1.2 1.75 12.01 9.15

EPS Revisions

GAAP
Normalized
Currency in EUR
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2026)
Next Year (2027)
Up Last 7 Days
-- -- 1 1
Up Last 30 Days
-- -- -- 1
Down Last 7 Days
2 2 1 1
Down Last 30 Days
2 -- 1 1

Growth Estimates

Symbol Current Qtr. Next Qtr. Current Year Next Year
ASND
-- -- -- -28.72%
S&P 500
49.60% 24.09% 31.59% 15.22%

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: